AB Science S.A. Profile Avatar - Palmy Investing

AB Science S.A.

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III cl…

Drug Manufacturers - Specialty & Generic
FR, Paris [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of AB.PA's Analysis
CIK: - CUSIP: - ISIN: FR0010557264 LEI: - UEI: -
Secondary Listings
AB.PA has no secondary listings inside our databases.